PURDY RICK LEIGH enters CEN BIOTECH INC with 215.72K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 5/3/2021ACC: 0001437749-21-010550
215.72K
Baseline shares
100% direct
215.72K
Direct ownership
1 position
93.75K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned215.72K
Total
215.72K direct215.72K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 215.72K | Direct |
| Total | 215.72K | 215.72K direct |
Derivative Holdings2
Convertible Note
DirectUnderlying security
Common Stock
Underlying shares
31.25K
Shares owned
N/A
Exercise price
1.6000
Expiration
—
Exercise window
—
Convertible Note
DirectUnderlying security
Common Stock
Underlying shares
62.50K
Shares owned
N/A
Exercise price
1.6000
Expiration
—
Exercise window
—
Total
Underlying
93.75K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Convertible Note Direct | Common Stock | 1.6000 | — | — | 31.25K | N/A |
| Convertible Note Direct | Common Stock | 1.6000 | — | — | 62.50K | N/A |
| Total | 93.75K | 0.00 | ||||